Pamela R. Matias-Garcia,Cavin K. Ward-Caviness,Laura M. Raffield,Xu Gao,Yan Zhang,Rory Wilson,Xin Gao,Jana Nano,Andrew Bostom,Elena Colicino,Adolfo Correa,Brent Coull,Charles Eaton,Lifang Hou,Allan C. Just,Sonja Kunze,Leslie Lange,Ethan Lange,Xihong Lin,Simin Liu,Jamaji C. Nwanaji-Enwerem,Alex Reiner,Jincheng Shen,Ben Schottker,Pantel Vokonas,Yinan Zheng,Bessie Young,Joel Schwartz,Steve Horvath,Ake Lu,Eric A. Whitsel,Wolfgang Koenig,Jerzy Adamski,Juliane Winkelmann,Hermann Brenner,Andrea A. Baccarelli,Christian Gieger,Annette Peters,Nora Franceschini,Melanie Waldenberger

Abstract:Background The difference between an individual's chronological and DNA methylation predicted age (DNAmAge), termed DNAmAge acceleration (DNAmAA), can capture life-long environmental exposures and age-related physiological changes reflected in methylation status. Several studies have linked DNAmAA to morbidity and mortality, yet its relationship with kidney function has not been assessed. We evaluated the associations between seven DNAm aging and lifespan predictors (as well as GrimAge components) and five kidney traits (estimated glomerular filtration rate [eGFR], urine albumin-to-creatinine ratio [uACR], serum urate, microalbuminuria and chronic kidney disease [CKD]) in up to 9688 European, African American and Hispanic/Latino individuals from seven population-based studies. Results We identified 23 significant associations in our large trans-ethnic meta-analysis (p < 1.43E-03 and consistent direction of effect across studies). Age acceleration measured by the Extrinsic and PhenoAge estimators, as well as Zhang's 10-CpG epigenetic mortality risk score (MRS), were associated with all parameters of poor kidney health (lower eGFR, prevalent CKD, higher uACR, microalbuminuria and higher serum urate). Six of these associations were independently observed in European and African American populations. MRS in particular was consistently associated with eGFR (beta = - 0.12, 95% CI = [- 0.16, - 0.08] change in log-transformed eGFR per unit increase in MRS, p = 4.39E-08), prevalent CKD (odds ratio (OR) = 1.78 [1.47, 2.16], p = 2.71E-09) and higher serum urate levels (beta = 0.12 [0.07, 0.16], p = 2.08E-06). The "first-generation" clocks (Hannum, Horvath) and GrimAge showed different patterns of association with the kidney traits. Three of the DNAm-estimated components of GrimAge, namely adrenomedullin, plasminogen-activation inhibition 1 and pack years, were positively associated with higher uACR, serum urate and microalbuminuria. Conclusion DNAmAge acceleration and DNAm mortality predictors estimated in whole blood were associated with multiple kidney traits, including eGFR and CKD, in this multi-ethnic study. Epigenetic biomarkers which reflect the systemic effects of age-related mechanisms such as immunosenescence, inflammaging and oxidative stress may have important mechanistic or prognostic roles in kidney disease. Our study highlights new findings linking kidney disease to biological aging, and opportunities warranting future investigation into DNA methylation biomarkers for prognostic or risk stratification in kidney disease.

EPIGENETIC PREDICTORS OF LIFESPAN AND HEALTHSPAN

DNA methylation GrimAge strongly predicts lifespan and healthspan

An epigenetic biomarker of aging for lifespan and healthspan

GENETIC PREDISPOSITION TO ACCELERATED BIOLOGICAL AGES PREDICTED BY BIOCHEMICAL MARKERS

DNA methylation-based biomarkers and the epigenetic clock theory of ageing

Epigenetic Predictor of Age

DNA Methylation Clocks and Their Predictive Capacity for Aging Phenotypes and Healthspan

Epigenetic measures of ageing predict the prevalence and incidence of leading causes of death and disease burden

Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging

A Novel Blood-Based Epigenetic Clock for Intrinsic Capacity Predicts Mortality and is Associated with Clinical, Immunological and Lifestyle Factors

Mortality Associations With DNA Methylation-Based Biological Aging and Physical Functioning Measures Across a 20-Year Follow-up Period

Quantification of Epigenetic Aging in Public Health

Epigenetic prediction of complex traits and death

Epigenetic clock: A promising biomarker and practical tool in aging

DNAm aging biomarkers are responsive: Insights from 51 longevity interventional studies in humans

DNAm-based Signatures of Accelerated Aging and Mortality in Blood Are Associated with Low Renal Function.

DNA Methylation-Based Biomarkers of Age Acceleration and All-Cause Death, Myocardial Infarction, Stroke, and Cancer in Two Cohorts: the NAS, and KORA F4

Epigenetic Clocks: In Aging-Related and Complex Diseases

The Blood DNA Methylation Clock GrimAge Is a Robust Surrogate for Airway Epithelia Aging

Many chronological aging clocks can be found throughout the epigenome: Implications for quantifying biological aging

Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing